DSpace Repository

Pravalence of Mitragynine in Forensic Autopsy Cases at the Forensic Investigation Center Chulalongkorn University from 2022 to 2023

Show simple item record

dc.contributor.author Nat Tansrisawad en_US
dc.contributor.author Apinya Tubtimrattana en_US
dc.date.accessioned 2025-07-09T04:23:51Z
dc.date.available 2025-07-09T04:23:51Z
dc.date.issued 2025-01-20
dc.identifier.citation GMS Medicine Journal. Vol.5, No.1 (January - April 2025) : p.25-30 en_US
dc.identifier.issn 2730-3446
dc.identifier.uri http://mfuir.mfu.ac.th:80/xmlui/handle/123456789/751
dc.description บทความ (Article) en_US
dc.description.abstract Background: Mitragynine is an active compound found in Kratom, a substance experiencing growing usage both in Thailand and globally. While Kratom is commonly perceived as safe with minimal adverse effects, instances of fatalities associated with its use and misuse have been documented. Objective: Investigating the prevalence of mitragynine in forensic autopsy cases from 2022 to 2023. Analyzing demographic data, causes of death, and proposed lethal level. Materials and Method: A retrospective study was conducted on the forensic toxicological analysis of 213 forensic autopsy cases from 2022 to 2023 at the Forensic Investigation Center of Chulalongkorn University. Results: The prevalence of positive mitragynine findings rose significantly from 3.14% in 2021 to 13.39% in the years 2022-2023. The male-to-female ratio was approximately 9:1. The common causes of death were attributed to traffic accidents, undetermined and cardiovascular diseases. Mitragynine concentrations varied widely, ranging from 0.10 to 1,423.23 ng/mL, with a mean concentration of 109.85 ng/mL. However, a definitive proposed lethal level could not be determined based on the data analyzed. Conclusion: The increasing use of kratom, coupled with the rising number of deaths associated with its consumption, necessitate a comprehensive reassessment of its safety profile. A thorough study on its safe usage, including potential positive effects and adverse reactions, is imperative. Additionally, regulatory measures governing kratom distribution and consumption require re-evaluation to ensure public safety and mitigate the risks associated with its use and misuse. en_US
dc.language.iso en en_US
dc.publisher School of Medicine, Mae Fah Luang University en_US
dc.subject Mitragynine en_US
dc.subject Prevalence en_US
dc.subject Prevalence en_US
dc.subject Forensic autopsy en_US
dc.title Pravalence of Mitragynine in Forensic Autopsy Cases at the Forensic Investigation Center Chulalongkorn University from 2022 to 2023 en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account